Code is covered without prior authorization (high confidence)
Medicare Pricing
Work RVU
0.00
Facility
N/A
Non-Facility
N/A
Documentation Required
Immune cell counts: B cells total (86355), Natural killer (NK) cells total (86357), T cells total (86359), absolute CD4 and CD8 count including ratio (86360), absolute CD4 count (86361) — listed as related tests (documentation of immune status when indicated)
Tissue culture for non-neoplastic disorders; skin or other solid tissue biopsy (CPT 88233) — listed as related diagnostic procedure
Pulmonary function testing where relevant: Measurement of lung volumes in infant/child through 2 years (CPT 94013); Plethysmography for lung volumes/airway resistance (94726); Gas dilution/washout for lung volumes and distribution of ventilation (94727); Airway resistance by oscillometry (94728) — listed as related tests (documentation requirement for pulmonary assessment)
Leukocyte and urinary glycosaminoglycan (uGAG) excretion testing: CPT 85048 (leukocyte testing) and CPT 83864 (Mucopolysaccharides, acid, quantitative) — listed as diagnostic tests for mucopolysaccharidoses
General: Precertification of enzyme replacement drugs required of all Aetna participating providers and members in applicable plan designs (call (866) 752-7021 or fax (888) 267-3277).
Ask Verity about documentation requirements, denial risks, or coverage in your state.
Precertification: Call (866) 752-7021 or fax (888) 267-3277; use Statement of Medical Necessity (SMN) precertification forms (Specialty Pharmacy Precertification).
Diagnosis confirmation: For most enzyme therapies, documentation must include diagnosis confirmation by enzyme assay demonstrating a deficiency of the specific enzyme activity or by genetic testing (this is explicitly required for Fabrazyme, Lumizyme, Nexviazyme, Brineura, Pombiliti, Vimizim, Naglazyme, Elaprase, Cerezyme/Elelyso/VPRIV for Gaucher, Aldurazyme, Xenpozyme, Lamzede, Mepsevii, Kanuma).